Cell Therapeutics (CTIC) NDA for Pixantrone To Be Reviewed by U.S. FDA in Feb. 2010
Tweet Send to a Friend
Cell Therapeutics, Inc. (NASDAQ: CTIC) announced today that on February 10, 2010 the U.S. Food and Drug Administration's Oncologic Drugs ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
